News and Publications
June 19, 2019
Advancing Actionable Clinical Support for Mental Health Providers
Consequences of CYP2D6 Copy-Number Variation for Pharmacogenomics in Psychiatry
Precision prescribing guided by pharmacogenomic (PGx) analysis offers the promise of powerful enhancement to the current standard of care for each individual psychiatric patient. While PGx analysis can better inform therapy and improve patient outcomes across a wide variety of clinical contexts, it should not be viewed as a panacea, according to new research from Coriell Life Sciences.
The co-authors explore best practices for overcoming many biological and technical challenges and explore a variety of current and future applications of PGx analysis of CYP2D6 in psychiatry in an article titled, “Consequences of CYP2D6 Copy-Number Variation for Pharmacogenomics in Psychiatry,” published online in Frontiers in Psychiatry.
April 23, 2019
RxGenomix and Coriell Life Sciences Announce Partnership
Combining a pharmacist-led implementation process with analytics and clinical decision support will provide a unique advantage for healthcare and benefit providers
RxGenomix, an innovative pharmacogenomics (PGx) solutions provider, and Coriell Life Sciences (CLS), the leading provider of clinical genetic reporting solutions, today announced a partnership that makes it easier for healthcare and benefit providers to more effectively deploy pharmacogenomics as a compelling clinical strategy. Together, their combined solution of claims analytics, clinical decision support, and a pharmacist-led offering seeks to make PGx more accessible and more effective in improving health while reducing overall healthcare costs.
May 20, 2018
Coriell Life Sciences Teams with Quantigen Genomics to Transform Women’s Health
New molecular women’s health report provides complete decision support for the detection of vaginal infections
Coriell Life Sciences (CLS), an innovative provider of clinical genetic reporting solutions, today announced the launch of their next-generation solution for the quantitative diagnosis and reporting of bacterial vaginosis (BV). The test can simultaneously aid in the differential diagnosis of other vaginal infections that clinically present with the same signs and symptoms as BV.
May 1, 2018
Coriell Life Sciences Pilot Partner Wins 2018 SALGBA Challenge Award
Teachers’ Retirement System of Kentucky personalized medicine pilot receives national recognition
Coriell Life Science is excited to share that Teachers’ Retirement System of Kentucky Personalized Medicine Project received a national award for health care innovation from the State and Local Government Benefits Association (SALGBA). Members of the TRS insurance team were on hand to accept the SALGBA Innovation Challenge Award at its annual national conference on May 1st, 2018.